National Bank of Canada
TXG icon

National Bank of Canada’s 10x Genomics TXG Stock Holding History

National Bank of Canada’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.91K Sell
128
-42
-25% -$1.1K ﹤0.01% 2564
2026
Q1 		$3.61K Buy
170
+132
+347% +$2.64K ﹤0.01% 2521
2025
Q4 		$619 Sell
38
-1,357
-97% -$20.5K ﹤0.01% 2676
2025
Q3 		$16.3K Sell
1,395
-184,612
-99% -$2.41M ﹤0.01% 2204
2025
Q2 		$2.15M Buy
+186,007
New +$1.7M ﹤0.01% 1128
2025
Q1 		– Sell
-105,700
Closed -$1.52M – 3161
2024
Q4 		$1.52M Buy
+105,700
New +$1.67M ﹤0.01% 1223
2024
Q3 		– Sell
-606
Closed -$11.3K – 3048
2024
Q2 		$11.3K Hold
606
– – ﹤0.01% 2102
2024
Q1 		$15.7K Hold
606
– – ﹤0.01% 2080
2023
Q4 		$32.9K Hold
606
– – ﹤0.01% 1896
2023
Q3 		$24.5K Hold
606
– – ﹤0.01% 1987
2023
Q2 		$33.8K Sell
606
-5
-0.8% -$271 ﹤0.01% 1885
2023
Q1 		$34.1K Buy
611
+505
+476% +$23.6K ﹤0.01% 1822
2022
Q4 		$3.86K Sell
106
-500
-83% -$16.3K ﹤0.01% 2383
2022
Q3 		$17K Buy
606
+540
+818% +$20.6K ﹤0.01% 2064
2022
Q2 		$3K Sell
66
-224
-77% -$11.6K ﹤0.01% 2561
2022
Q1 		$22K Hold
290
– – ﹤0.01% 2155
2021
Q4 		$43K Buy
+290
New +$44.4K ﹤0.01% 1925

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

National Bank of Canada's TXG Position: Q2 2026 in Review

National Bank of Canada reduced its 10x Genomics (TXG) stake by 25% in Q2 2026, selling an estimated $1.1K and leaving 128 shares worth $4.91K. The position accounts for ﹤0.01% of the portfolio, ranked #2564.

National Bank of Canada first reported a position in TXG in Q4 2021 and has held it in 17 quarters since. The position peaked at $2.15M in Q2 2025. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • National Bank of Canada held 128 shares of 10x Genomics worth $4.91K as of Q2 2026.
  • National Bank of Canada sold 42 10x Genomics shares in Q2 2026, an estimated $1.1K.
  • 10x Genomics made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #2564 holding.
  • National Bank of Canada first reported a position in 10x Genomics in Q4 2021 and has held it in 17 quarters since.
  • National Bank of Canada's 10x Genomics position peaked at $2.15M in Q2 2025.
  • 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.